Adam S Faye

28PUBLICATIONS
47CO-AUTHORS
Social epidemiologyInnate immunityImmunogenetics (incl. genetic immunology)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 22, 2026
Letter: Does the Association Between Mild Endoscopic Activity and Adverse Outcomes Justify Treatment Escalation in Older Adults With Inflammatory Bowel Disease? Authors' Reply.

|Apr 15, 2026
Corticosteroid Initiation Before Antimicrobials Does Not Increase the Risk of Adverse Outcomes Among Individuals Hospitalized With an IBD Flare and Enteric Infection.

|Feb 13, 2026
The Bidirectional Relationship Between Cognitive Function and Active Inflammatory Bowel Disease.

Bharati Kochar, Adam S Faye, Elizabeth Araka

|Feb 10, 2026
Proton Pump Inhibitors Are More Cost-Effective Than Potassium Competitive Acid Blockers for Gastroesophageal Reflux Disease.

Kate L Karlin, Ella H Gilbert, Francesca Lim

|Nov 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.

Adam S Faye, David T Rubin, Corey A Siegel

|Nov 20, 2025
Editorial: Remission Ambition-How Far Should We Push in Older Adults? Authors' Reply.

Catherine Z Tang, Adam S Faye

Pageof 5

Frequent Collaborators

5 joint publications

Jordan E Axelrad

3 joint publications

Kate L Karlin

2 joint publications

Chin Hur

2 joint publications

Bharati Kochar